HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer.

AbstractPURPOSE:
The aim of this study was to show the benefit of a two-step intensity modulated radiotherapy (IMRT) method by examining geometric and dosimetric changes.
MATERIAL AND METHODS:
Twenty patients with pharyngeal cancers treated with two-step IMRT combined with chemotherapy were included. Treatment-planning CT was done twice before IMRT (CT-1) and at the third or fourth week of IMRT for boost IMRT (CT-2). Transferred plans recalculated initial plan on CT-2 were compared with the initial plans on CT-1. Dose parameters were calculated for a total dose of 70 Gy for each plan.
RESULTS:
The volumes of primary tumors and parotid glands on CT-2 regressed significantly. Parotid glands shifted medially an average of 4.2mm on CT-2. The mean doses of the parotid glands in the initial and transferred plans were 25.2 Gy and 30.5 Gy, respectively. D(2) (dose to 2% of the volume) doses of the spinal cord were 37.1 Gy and 39.2 Gy per 70 Gy, respectively. Of 15 patients in whom xerostomia scores could be evaluated 1-2 years after IMRT, no patient complained of grade 2 or more xerostomia.
CONCLUSIONS:
This two-step IMRT method as an adaptive RT scheme could adapt to changes in body contour, target volumes and risk organs during IMRT.
AuthorsTamaki Nishi, Yasumasa Nishimura, Toru Shibata, Masaya Tamura, Naohiro Nishigaito, Masahiko Okumura
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Radiother Oncol) Vol. 106 Issue 1 Pg. 85-9 (Jan 2013) ISSN: 1879-0887 [Electronic] Ireland
PMID23337058 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Topics
  • Head and Neck Neoplasms (pathology, radiotherapy)
  • Humans
  • Parotid Gland (radiation effects)
  • Radiotherapy Dosage
  • Radiotherapy, Intensity-Modulated (methods)
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: